首页> 外文期刊>Schweizer Archiv fur Tierheilkunde >Vaccinovigilance: Reported adverse reactions of immunological veterinary medicinal products in 2018
【24h】

Vaccinovigilance: Reported adverse reactions of immunological veterinary medicinal products in 2018

机译:疫苗病:2018年报告了免疫兽医药品的不良反应

获取原文
获取原文并翻译 | 示例
           

摘要

The registration of adverse events after the use of immunological veterinary medicinal products (VMP) is the aim of the vaccinovigilance reporting system in Switzerland. Adverse events comprise suspected adverse reactions and lack of expected efficacy. Since the Institute of virology and immunology (IVI) is the competent authority for the regulation of immunological VMP in Switzerland, the reporting system is administrated by the IVI. In 2018, 162 reports concerning authorized immunological VMP were received. While most of the reports were submitted by the marketing authorization holders (79%), practicing veterinary surgeons contributed to the reporting system, too (18%). Five reports were submitted by private persons (3%). Dogs were mainly affected (43%) with several terrier breeds and chihuahuas being the most frequently reported dog breeds. Further reports were related to cats (16%), cattle (14%) and horses (14%). Recently, the numbers of reports concerning cats (+26) and horses (+23) have considerably increased after there had been clearly less reports concerning these species (11 and 5, respectively) in the previous year. Most of the reports were based on the application of combined vaccines against canine distemper, hepatitis, parvovirosis and parainfluenza with or without leptospirosis in dogs as well as cat flu and feline panleukopenia in cats. In 29.6% of the submitted cases, the causality assessment between the vaccination and the reaction described was evaluated probable.
机译:使用免疫兽医药品(VMP)使用后不良事件的登记是瑞士疫苗道报告系统的目的。不良事件包括疑似不良反应和缺乏预期的疗效。由于病毒学和免疫学(IVI)研究所是瑞士监管免疫学VMP的主管当局,报告系统由IVI管理。 2018年,收到了有关授权免疫学VMP的162个报告。虽然大多数报告由营销授权持有人(79%)提交,但练习兽医捐赠给报告系统(18%)。五个报告由私人提交(3%)。狗主要受到影响(43%),几个梗出品种和奇瓦瓦斯是最常见的狗品种。进一步的报告与猫(16%),牛(14%)和马(14%)有关。最近,有关猫(+26)和马匹(+23)的报告数量在上一年的这些物种(11和5分别)显然较少后大幅增加。大多数报告都基于将疫苗的组合疫苗对犬瘟热,肝炎,细分病毒病和Parainfluenza的应用,或没有狗血吸虫病以及猫流感和猫的猫咪Panleukopenia。在提交病例的29.6%中,评估疫苗接种和所述反应之间的因果关系评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号